Diamyd Medical selects Cytiva’s FlexFactory platform to make precision medicine type 1 diabetes vaccine

· FlexFactory platform enables Diamyd Medical to manufacture its key protein GAD65 for type 1 diabetes precision medicine vaccine  · Diamyd Medical’s biologics manufacturing is located in Umeå, Sweden  · FlexFactory is a configurable single-use bioprocess manufacturing platform Diamyd Medical will install a new Cytiva FlexFactory platform in Umeå, Sweden. Once up and running, the clinical stage biopharmaceutical company will begin manufacturing its precision medicine vaccine. The first of its kind, the type 1 diabetes vaccine works to reprogram immune cells to prevent the